Leukemia & Lymphoma Society Inc - Strategic SWOT Analysis Review

June 2020 | 34 pages | ID: L4ABCFC25FEEN
GlobalData

Abstracts

Leukemia & Lymphoma Society Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

The Leukemia & Lymphoma Society Inc (LLS) is a voluntary health organization that focuses on funding research for identifying cure for blood cancer. The organization also assures access to treatments for blood cancer patients. Its offers patient support, health education, policy advocacy, and raises funds and funds for medical research. LLS’ provides treatment for various diseases, including leukemia, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasms and myeloma. The organization works in collaboration with pharmaceutical and biotechnology companies, patients support services and advocates working for blood cancer patients. It has operations in the US and Canada. LLS is headquartered in Rye Brook, New York, the US.

Leukemia & Lymphoma Society Inc Key Recent Developments

May 19,2020: Protocol first announces strategic investment from The Leukemia & Lymphoma Society to advance clinical trial execution
May 19,2020: Protocol first announces strategic investment from The Leukemia & Lymphoma Society (LLS) to advance clinical trial execution
Apr 01,2020: LLS and partners commit $4.5 million for blood cancer patients impacted by COVID-19
Dec 06,2019: LLS and ASH team up to connect cancer patients to clinical trials
Jul 11,2019: Advancing Leading Edge Cancer Research in a $4.5 million collaboration

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Leukemia & Lymphoma Society Inc - Key Facts
Leukemia & Lymphoma Society Inc - Key Employees
Leukemia & Lymphoma Society Inc - Key Employee Biographies
Leukemia & Lymphoma Society Inc - Major Products and Services
Leukemia & Lymphoma Society Inc - History
Leukemia & Lymphoma Society Inc - Company Statement
Leukemia & Lymphoma Society Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Leukemia & Lymphoma Society Inc - Business Description
Leukemia & Lymphoma Society Inc - Corporate Strategy
Leukemia & Lymphoma Society Inc - SWOT Analysis
SWOT Analysis - Overview
Leukemia & Lymphoma Society Inc - Strengths
Leukemia & Lymphoma Society Inc - Weaknesses
Leukemia & Lymphoma Society Inc - Opportunities
Leukemia & Lymphoma Society Inc - Threats

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Leukemia & Lymphoma Society Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 19, 2020: Protocol first announces strategic investment from The Leukemia & Lymphoma Society (LLS) to advance clinical trial execution
May 19, 2020: Protocol first announces strategic investment from The Leukemia & Lymphoma Society to advance clinical trial execution
Apr 01, 2020: LLS and partners commit $4.5 million for blood cancer patients impacted by COVID-19
Dec 06, 2019: LLS and ASH team up to connect cancer patients to clinical trials
Jul 11, 2019: Advancing Leading Edge Cancer Research in a $4.5 million collaboration
Jan 15, 2019: The Leukemia & Lymphoma Society (LLS) continues to drive progress to cancer cures

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Leukemia & Lymphoma Society Inc, Key Facts
Leukemia & Lymphoma Society Inc, Key Employees
Leukemia & Lymphoma Society Inc, Key Employee Biographies
Leukemia & Lymphoma Society Inc, Major Products and Services
Leukemia & Lymphoma Society Inc, History
Leukemia & Lymphoma Society Inc, Subsidiaries
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Leukemia & Lymphoma Society Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020